X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
androgen receptor (4) 4
breast cancer (4) 4
oncology (4) 4
seviteronel (4) 4
androgens (3) 3
enzalutamide (3) 3
humans (3) 3
identification (3) 3
index medicus (3) 3
medicine & public health (3) 3
prostate (3) 3
prostate cancer (3) 3
subtypes (3) 3
abiraterone acetate (2) 2
androgen receptor antagonists - pharmacokinetics (2) 2
antineoplastic agents - pharmacokinetics (2) 2
antineoplastic agents - therapeutic use (2) 2
antitumor agents (2) 2
bicalutamide (2) 2
breast neoplasms - drug therapy (2) 2
development and progression (2) 2
estrogen (2) 2
female (2) 2
metastases (2) 2
pharmacokinetics (2) 2
receptors, androgen - metabolism (2) 2
steroid 17-alpha-hydroxylase - antagonists & inhibitors (2) 2
triple negative breast neoplasms - drug therapy (2) 2
triple negative breast neoplasms - metabolism (2) 2
women (2) 2
abiraterone (1) 1
aged (1) 1
aged, 80 and over (1) 1
androgen antagonists - therapeutic use (1) 1
androgen receptor antagonists - administration & dosage (1) 1
androgen receptor antagonists - adverse effects (1) 1
androgen receptor antagonists - therapeutic use (1) 1
antagonism (1) 1
anticancer properties (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic agents - pharmacology (1) 1
biological availability (1) 1
biomarkers, tumor (1) 1
body weight (1) 1
breast neoplasms - metabolism (1) 1
breast neoplasms - pathology (1) 1
cancer (1) 1
cancer research (1) 1
care and treatment (1) 1
castration (1) 1
classification (1) 1
clinical trials (1) 1
clinical trials, phase ii as topic (1) 1
combination (1) 1
computer simulation (1) 1
covariance (1) 1
cyp17 lyase (1) 1
cytochrome (1) 1
cytochrome p-450 (1) 1
cytochromes (1) 1
dexamethasone (1) 1
dexamethasone - pharmacokinetics (1) 1
dna damage repair (1) 1
dna-repair (1) 1
dose-response relationship, drug (1) 1
drug monitoring - methods (1) 1
drug therapy, combination - methods (1) 1
efficacy (1) 1
endocrinology & metabolism (1) 1
epidermal growth factor (1) 1
estrogen receptors (1) 1
estrogen-receptor (1) 1
exemestane (1) 1
expression (1) 1
fatigue (1) 1
fluoxymesterone (1) 1
health aspects (1) 1
hematology, oncology and palliative medicine (1) 1
inhibitors (1) 1
internal medicine (1) 1
male (1) 1
men (1) 1
metastasis (1) 1
middle aged (1) 1
molecular targeted therapy (1) 1
naphthalenes - pharmacokinetics (1) 1
nausea (1) 1
neoplasm staging (1) 1
oral administration (1) 1
palbociclib (1) 1
parameters (1) 1
pharmacology (1) 1
pharmacology/toxicology (1) 1
phenols (1) 1
population pharmacokinetics (1) 1
postmenopausal patients (1) 1
postmenopausal women (1) 1
preclinical models (1) 1
prednisone (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Breast cancer research and treatment, ISSN 1573-7217, 2018, Volume 171, Issue 1, pp. 111 - 120
Journal Article
FRONTIERS IN ENDOCRINOLOGY, ISSN 1664-2392, 02/2020, Volume 11, p. 35
Increased rates of locoregional recurrence (LR) have been observed in triple negative breast cancer (TNBC) despite multimodality therapy, including radiation... 
PROSTATE | SUBTYPES | seviteronel (INO-464) | IDENTIFICATION | ESTROGEN-RECEPTOR | radiation | PRECLINICAL MODELS | ENDOCRINOLOGY & METABOLISM | androgen receptor (AR) | TNBC (triple negative breast cancer) | radiosensitization agents | DNA-REPAIR | DNA damage repair (DDR) | enzalutamide (MDV3100) | ENZALUTAMIDE
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 10/2019, Volume 84, Issue 4, pp. 759 - 770
Journal Article
Current Breast Cancer Reports, ISSN 1943-4588, 12/2017, Volume 9, Issue 4, pp. 242 - 250
Emerging evidence has identified the androgen receptor (AR) pathway as a potential driver for breast cancer (BC) carcinogenesis. The prevalence of AR... 
Medicine & Public Health | Abiraterone | Androgen receptor | Oncology | Internal Medicine | Bicalutamide | Enzalutamide | Surgical Oncology | Triple-negative breast cancer | Seviteronel | Androgens | Care and treatment | Breast cancer | Health aspects | Cancer
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.